Ortho Regenerative Technologies Adds Patrick O Donnell to Board of Directors
News provided by
Share this article
Ortho RTI or the
Company ), a clinical stage orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, announced today the appointment of Patrick O Donnell to its Board of Directors, effective immediately. We are very pleased to welcome Patrick to the Ortho RTI Board of Directors to help lead a very important transition in the development of our company, as we prepare to start our first U.S. multisite Ortho-R rotator cuff tear repair Phase I/II clinical trial, said Claude LeDuc, President and Chief Executive Officer of Ortho RTI. Ortho RTI will greatly benefit from Patrick s company-building experience as well as his expertise in the development and management of strategic partnerships fund-raising, commercial, clinical, regulatory and reimbursement strategies, all specific to our industry. We are looking forward to